Abstract
Pharmaceutical manufacturing on a large scale and the presence of pharmaceuticals in the environment have sparked growing concern. The life cycle assessment (LCA) technique is an efficient tool for analyzing any potential environmental impacts associated with pharmaceuticals at each step of their life cycle. This study presents research trends and future directions of pharma-LCAs through bibliometric indicators. The Scopus database was used to collect the literature dataset. Between 2000 and 2022, a total of 207 documents involving “pharmaceutical” and “LCA” were released. Numerous aspects of these documents, including subject categories, journals, articles, countries, affiliations, funding sponsors, authors, and keywords, have been systematically examined in this research. Collaborations between authors and countries were visualized and analyzed by using social network analysis based on co-authorship relations. Additionally, keywords were clustered using co-occurrence relations to discover the most trending topics in the literature review. The research showed that as an evolutionary process, the utilization of the life cycle assessment method has continued to increase in the pharmaceutical sector within the period. As well, the principal focus of studies has been on pharmaceuticals for human consumption. The analysis of extracted keywords reveals that green chemistry, energy efficiency, and sustainable pharmacy have always been the main topics. However, in recent years, researchers' focus has shifted to environmental impacts, carbon footprint, wastewater treatment, human toxicity, active pharmaceutical ingredients and blisters.
Graphical Abstract
Similar content being viewed by others
Availability data and material
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Adams JP, Alder CM, Andrews I et al (2013) Development of GSK’s reagent guides–embedding sustainability into reagent selection. Green Chem 15:1542. https://doi.org/10.1039/c3gc40225h
Artz J, Müller TE, Thenert K et al (2018) Sustainable conversion of carbon dioxide: an integrated review of catalysis and life cycle assessment. Chem Rev 118:434–504. https://doi.org/10.1021/acs.chemrev.7b00435
Braund R, Peake BM, Tremblay LA (2015) The life-cycle of pharmaceuticals in the environment. Elsevier Science & Technology
Curzons AD, Jiménez-González C, Duncan AL et al (2007) Fast life cycle assessment of synthetic chemistry (FLASC™) tool. Int J Life Cycle Assess 12:272–280. https://doi.org/10.1065/lca2007.03.315
de Jonge AM (2003) Limited LCAs of pharmaceutical products: merits and limitations of an environmental management tool. Corp Soc Responsib Environ Manag 10:78–90. https://doi.org/10.1002/csr.36
Emara Y, Lehmann A, Siegert M-W, Finkbeiner M (2019) Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): a review. Integr Environ Assess Manag 15:6–18. https://doi.org/10.1002/ieam.4100
González Peña OI, López Zavala MÁ, Cabral Ruelas H (2021) Pharmaceuticals market, consumption trends and disease incidence are not driving the pharmaceutical research on water and wastewater. Int J Environ Res Public Health 18:2532. https://doi.org/10.3390/ijerph18052532
He X, Yu D (2020) Research trends in life cycle assessment research: a 20-year bibliometric analysis (1999–2018). Environ Impact Assess Rev 85:106461. https://doi.org/10.1016/j.eiar.2020.106461
Hospido A, Carballa M, Moreira M et al (2010) Environmental assessment of anaerobically digested sludge reuse in agriculture: potential impacts of emerging micropollutants. Water Res 44:3225–3233. https://doi.org/10.1016/j.watres.2010.03.004
Jiménez-González C, Overcash MR (2014) The evolution of life cycle assessment in pharmaceutical and chemical applications–a perspective. Green Chem 16:3392–3400. https://doi.org/10.1039/C4GC00790E
Jiménez-González C, Curzons AD, Constable DJC, Cunningham VL (2004) Cradle-to-gate life cycle inventory and assessment of pharmaceutical compounds. Int J Life Cycle Assess 9:114–121. https://doi.org/10.1007/BF02978570
Jiménez-González C, Poechlauer P, Broxterman QB et al (2011) Key green engineering research areas for sustainable manufacturing: a perspective from pharmaceutical and fine chemicals manufacturers. Org Process Res Dev 15:900–911. https://doi.org/10.1021/op100327d
Jiménez-González C, Constable DJC, Ponder CS (2012) Evaluating the “Greenness” of chemical processes and products in the pharmaceutical industry—a green metrics primer. Chem Soc Rev 41:1485–1498. https://doi.org/10.1039/C1CS15215G
Jimenez-Gonzalez C, Ponder CS, Broxterman QB, Manley JB (2011) Using the right green yardstick: why process mass intensity is used in the pharmaceutical industry to drive more sustainable processes. Org Process Res Dev 15:912–917. https://doi.org/10.1021/op200097d
Jimenez-Gonzalez C, others (2002) Life Cycle Assessment in Pharmaceutical Applications.
Kralisch D, Ott D, Gericke D (2015) Rules and benefits of life cycle assessment in green chemical process and synthesis design: a tutorial review. Green Chem 17:123–145. https://doi.org/10.1039/C4GC01153H
Kümmerer K (2010) Pharmaceuticals in the Environment. Annu Rev Environ Resour 35:57–75. https://doi.org/10.1146/annurev-environ-052809-161223
Li L-L, Ding G, Feng N et al (2009) Global stem cell research trend: bibliometric analysis as a tool for mapping of trends from 1991 to 2006. Scientometrics 80:39–58. https://doi.org/10.1007/s11192-008-1939-5
Michael ZH, Ralph KR, Stig IO (2018) Life cycle assessment: theory and practice
Mikulic M (2022) Revenue of the worldwide pharmaceutical market from 2001 to 2021. https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/
Muñoz I, José Gómez M, Molina-Díaz A et al (2008) Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere 74:37–44. https://doi.org/10.1016/j.chemosphere.2008.09.029
Muñoz I, Rodríguez A, Rosal R, Fernández-Alba AR (2009) Life cycle assessment of urban wastewater reuse with ozonation as tertiary treatment. Sci Total Environ 407:1245–1256. https://doi.org/10.1016/j.scitotenv.2008.09.029
Ott D, Kralisch D, Denčić I et al (2014) Life cycle analysis within pharmaceutical process optimization and intensification: case study of active pharmaceutical ingredient production. Chemsuschem 7:3521–3533. https://doi.org/10.1002/cssc.201402313
Otte E, Rousseau R (2002) Social network analysis: a powerful strategy, also for the information sciences. J Inf Sci 28:441–453. https://doi.org/10.1177/016555150202800601
Parvatker AG, Tunceroglu H, Sherman JD et al (2019) Cradle-to-gate greenhouse gas emissions for twenty anesthetic active pharmaceutical ingredients based on process scale-up and process design calculations. ACS Sustain Chem Eng 7:6580–6591. https://doi.org/10.1021/acssuschemeng.8b05473
Raymond MJ, Slater CS, Savelski MJ (2010) LCA approach to the analysis of solvent waste issues in the pharmaceutical industry. Green Chem 12:1826–1834
Robert C, Saenz-Feijoo R, Gaudy J-F, Arreto C-D (2009) Quantitative analysis of the scientific literature on acetaminophen in medicine and biology: a 2003–2005 study. Fundam Clin Pharmacol 23:159–168. https://doi.org/10.1111/j.1472-8206.2008.00655.x
Roschangar F, Sheldon RA, Senanayake CH (2015) Overcoming barriers to green chemistry in the pharmaceutical industry–the green aspiration level™ concept. Green Chem 17:752–768. https://doi.org/10.1039/C4GC01563K
Savelski M, Slater CS, Dunn P et al (2011) Use of life cycle assessment to evaluate the sustainable manufacture of the active pharmaceutical ingredient pregabalin
Sheldon RA (2005) Green solvents for sustainable organic synthesis: state of the art. Green Chem 7:267. https://doi.org/10.1039/b418069k
Sheldon RA (2018) Metrics of green chemistry and sustainability: past, present, and future. ACS Sustain Chem Eng 6:32–48. https://doi.org/10.1021/acssuschemeng.7b03505
Siegert M-W, Lehmann A, Emara Y, Finkbeiner M (2019b) Harmonized rules for future LCAs on pharmaceutical products and processes. Int J Life Cycle Assess 24:1040–1057
Siegert M-W, Saling P, Mielke P et al (2020) Cradle-to-grave life cycle assessment of an ibuprofen analgesic. Sustain Chem Pharm 18:100329. https://doi.org/10.1016/j.scp.2020.100329
Siegert M-W, Finkbeiner M, Emara Y, Lehmann A (2019a) Product Category Rules (PCR) for pharmaceutical products and processes. https://doi.org/10.14279/depositonce-9143
Singh J, Gu S (2010) Commercialization potential of microalgae for biofuels production. Renew Sustain Energy Rev 14:2596–2610. https://doi.org/10.1016/j.rser.2010.06.014
Taylor D (2015) The Pharmaceutical Industry and the Future of Drug Development. Royal Society of Chemistry, pp 1–33
Wernet G, Conradt S, Isenring HP et al (2010) Life cycle assessment of fine chemical production: a case study of pharmaceutical synthesis. Int J Life Cycle Assess 15:294–303. https://doi.org/10.1007/s11367-010-0151-z
Zyoud S, Al-Jabi S, Sweileh W (2015) Worldwide research productivity of paracetamol (acetaminophen) poisoning. Hum Exp Toxicol 34:12–23. https://doi.org/10.1177/0960327114531993
Acknowledgements
The authors would like to acknowledge K. N. Toosi University of Technology for their valuable supports throughout this study.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. This publication has not been funded by any organization or individuals.
Author information
Authors and Affiliations
Contributions
MRS, HZ, and MH have contributed equally. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Editorial responsibility: Samareh Mirkia.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sabour, M.R., Zarrabi, H. & Hajbabaie, M. A systematic analysis of research trends on the utilization of life cycle assessment in pharmaceutical applications. Int. J. Environ. Sci. Technol. 20, 10921–10942 (2023). https://doi.org/10.1007/s13762-023-05103-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13762-023-05103-4